...gt;> 首页 > 专家 > 内容 文献名称：生长抑素受体与甲状腺眼病 前言： 目前认为甲状腺眼病(thyroid eye disease,TED)是一种自身免疫性疾病。临床上判断TED活动性对治疗方法的选择十分重要。
基于36个网页-相关网页
甲状腺眼病 甲状腺眼病(Thyroid ophthalmopathy)是一种因免疫系统紊乱而引致的眼病。病人大部分为25-50岁，以女性居多。
基于6个网页-相关网页
目前认为甲状腺眼病 thyroid eye disease ; TED
甲状腺相关眼病 TAO ; thyroid associated ophthalmopathy ; thyroedid related ophthalmopathy ; thyroid-associated
甲状腺相关性眼病 TAO ; thyroid associated ophthalmopathy ; thyroid eye disease ; TED
甲状腺毒性眼病 thyrotoxic ophthalmic disease ; thyroid-related immune orbitopathy ; endocrinic external myopathy
甲状腺眼外肌肌病 endocrinic external myopathy ; thyroid-related immune orbitopathy ; thyrotoxic ophthalmic disease
在甲状腺相关眼病 thyroid associated ophthalmopathy ; TAO
治疗甲状腺相关眼病 thyroid associated ophthalmopathy ; TAO
甲状腺干系眼病 thyroid associated ophthalmopathy ; TAO
重症甲状腺相关眼病 thyroid associated ophthalmopathy ; TAO
目的：观察甲强龙冲击疗法治疗甲状腺眼病的治疗效果。
Objective: To explore the effect of methylprednisolone in the treatment of Graves ophthalmopathy.
目的对比观察传统与新型免疫抑制剂对自身免疫性甲状腺眼病的疗效。
Objective to compare the curative effects between the traditional and new immunosuppressants in autoimmune thyroid ophthalmopathy.
结论M MF治疗甲状腺眼病疗效优于小剂量糖皮质激素和雷公藤总萜片。
Conclusion MMF may be more effective than glucocorticoid and tripterygium preparation in regular dose in the treatment of thyroid ophthalmopathy.
应用推荐